Acorda Therapeutics Inc
OTC:ACORQ
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACORQ's stock price target?
Not Available
ACORQ doesn't have any price targets made by Wall Street professionals.
What is Acorda Therapeutics Inc's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Acorda Therapeutics Inc's revenue is
-4%.
The projected
CAGR
for the next 3 years is
9%.